De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features

Volkan Okur, Megan T. Cho, Lindsay Henderson, Kyle Retterer, Michael Schneider, Shannon Sattler, Dmitriy Niyazov, Meron Azage, Sharon Smith, Jonathan Picker, Sharyn Lincoln, Mark Tarnopolsky, Lauren Brady, Hans Tomas Bjornsson, Carolyn Applegate, Amy Dameron, Rebecca Willaert, Berivan Baskin, Jane Juusola, Wendy K. Chung

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

Whole exome sequencing (WES) can be used to efficiently identify de novo genetic variants associated with genetically heterogeneous conditions including intellectual disabilities. We have performed WES for 4102 (1847 female; 2255 male) intellectual disability/developmental delay cases and we report five patients with a neurodevelopmental disorder associated with developmental delay, intellectual disability, behavioral problems, hypotonia, speech problems, microcephaly, pachygyria and dysmorphic features in whom we have identified de novo missense and canonical splice site mutations in CSNK2A1, the gene encoding CK2α, the catalytic subunit of protein kinase CK2, a ubiquitous serine/threonine kinase composed of two regulatory (β) and two catalytic (α and/or α′) subunits. Somatic mutations in CSNK2A1 have been implicated in various cancers; however, this is the first study to describe a human condition associated with germline mutations in any of the CK2 subunits.

Original languageEnglish (US)
Pages (from-to)699-705
Number of pages7
JournalHuman genetics
Volume135
Issue number7
DOIs
StatePublished - Jul 1 2016

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features'. Together they form a unique fingerprint.

Cite this